Inventor · disambiguated record

Andreas G. Moraitis

Also filed as: MORAITIS ANDREAS · MORAITIS ANDREAS G

32 granted patents·13 pending applications·110 citations·filing 2016–2025

96Inventor score

Technology areasA61K A61P G01N

Files withCORCEPT THERAPEUTICS INC45

Top patents by PatentIndex Score

45 records

0198US11058670B2Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorCORCEPT THERAPEUTICS INC·Filed 2020·Granted Jul 13, 2021·13 cites·22 claims
0298US9829495B2Method for differentially diagnosing ACTH-dependent Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2016·Granted Nov 28, 2017·26 cites·18 claims
0397US11684612B2Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorCORCEPT THERAPEUTICS INC·Filed 2022·Granted Jun 27, 2023·8 cites·20 claims
0497US11590113B2Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorCORCEPT THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·8 cites·22 claims
0596US11744837B2Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patientsCORCEPT THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·4 cites·7 claims
0695US11890289B2Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2021·Granted Feb 6, 2024·4 cites·9 claims
0795US11793810B2Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2021·Granted Oct 24, 2023·2 cites·18 claims
0895US11202784B2Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2020·Granted Dec 21, 2021·5 cites·11 claims
0994US10151763B2Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·6 cites·30 claims
1092US11327083B2Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2018·Granted May 10, 2022·4 cites·29 claims
1192US10314850B1Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patientsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Jun 11, 2019·4 cites·30 claims
1291US11213526B2Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Jan 4, 2022·3 cites·34 claims
1390US11524013B2Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Dec 13, 2022·2 cites·21 claims
1489US11268145B2Methods for treating Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2017·Granted Mar 8, 2022·3 cites·2 claims
1589US10006924B2Method for differentially diagnosing ACTH-dependent cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2017·Granted Jun 26, 2018·2 cites·18 claims
1688US10604807B2Methods for diagnosing and assessing treatment for Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2016·Granted Mar 31, 2020·3 cites·5 claims
1786US10610534B2Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2016·Granted Apr 7, 2020·2 cites·9 claims
1886US2023324415A1Method for differentially diagnosing acth-dependent cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
1985US12336985B2Methods for shrinking pituitary tumorsCORCEPT THERAPEUTICS INC·Filed 2024·Granted Jun 24, 2025·0 cites·18 claims
2085US2024408108A1Treatment of Hypercoagulopathy in Cushing's Syndrome by Administration of Glucocorticoid Receptor ModulatorsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2185US2025009721A1Therapeutic Uses of Relacorilant, a Heteroaryl-ketone Fused Azadecalin Glucocorticoid Receptor ModulatorCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2283US12102642B2Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2022·Granted Oct 1, 2024·0 cites·10 claims
2383US11234971B2Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agentCORCEPT THERAPEUTICS INC·Filed 2020·Granted Feb 1, 2022·2 cites·24 claims
2483US10231983B1Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patientsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Mar 19, 2019·3 cites·30 claims
2582US12097192B2Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorCORCEPT THERAPEUTICS INC·Filed 2023·Granted Sep 24, 2024·0 cites·20 claims
2681US12263169B2Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2023·Granted Apr 1, 2025·0 cites·14 claims
2781US11389432B2Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agentCORCEPT THERAPEUTICS INC·Filed 2019·Granted Jul 19, 2022·2 cites·19 claims
2881US2024156835A1Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
2981US2025375433A1Methods for shrinking pituitary tumorsCORCEPT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
3080US10780097B2Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patientsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Sep 22, 2020·2 cites·7 claims
3179US11073523B2Method for differentially diagnosing ACTH-dependent Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2019·Granted Jul 27, 2021·0 cites·20 claims
3279US10946005B2Methods for shrinking pituitary tumorsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Mar 16, 2021·1 cites·30 claims
3376US2024245659A1Methods of Treating Cushing's Syndrome and Liver Disorders, and of Reducing Liver Toxicity of Other Drugs Administered to a PatientCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
3476US2021311079A1Method for differentially diagnosing acth-dependent cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
3574US12005055B2Methods for shrinking pituitary tumorsCORCEPT THERAPEUTICS INC·Filed 2021·Granted Jun 11, 2024·0 cites·20 claims
3674US11202787B2Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patientsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Dec 21, 2021·1 cites·20 claims
3773US2023372312A1Methods of Treating Cushing's syndrome and Liver Disorders, and of Reducing Liver Toxicity of Other Drugs Administered to a PatientCORCEPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
3871US10495650B2Method for differentially diagnosing ACTH-dependent Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·0 cites·17 claims
3969US2024390341A1Methods for treating adrenal gland tumorsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
4063US2020216905A1Methods for diagnosing and assessing treatment for cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
4161US2024197716A1Treatments for cushing's syndrome that do not significantly affect cardiac rhythmsCORCEPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
4257US12290551B2Methods for imaging and treatment of somatostatin-receptor positive tumorsCORCEPT THERAPEUTICS INC·Filed 2019·Granted May 6, 2025·0 cites·8 claims
4354US2023358768A1Treatment of, and differential diagnosis between, acth-dependent cushing's syndrome and acth-independent cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
4444US11045482B2Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumorsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Jun 29, 2021·0 cites·30 claims
4541US2018125856A1Use of glucocorticoid receptor antagonist and somatostatin analogues to treat acth-secreting tumorsCORCEPT THERAPEUTICS INC·Filed 2017·Application pending·0 cites

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →